Retrieve available abstracts of 211 articles: HTML format
Single Articles
May 2025
RUDMAN SPERGEL AK, Wu I, Deng W, Cardona J, et al Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in
Adults >/=50 Years: A Randomized Clinical Trial.
JAMA. 2025 May 7:e255646. doi: 10.1001/jama.2025.5646. PubMedAbstract available
April 2025
MOIN EE, Seewald NJ, Halpern SD Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units.
JAMA. 2025 Apr 14:e252163. doi: 10.1001/jama.2025.2163. PubMedAbstract available
February 2025
WU PH, Ho YY, Chang CM Electronic Nudges for Influenza Vaccination.
JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26532. PubMed
JOHANSEN ND, Biering-Sorensen T Electronic Nudges for Influenza Vaccination-Reply.
JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26535. PubMed
January 2025
BOCK A CDC Advises Expedited Influenza Subtyping in Hospitalized Patients to Help
Identify Bird Flu Cases Sooner.
JAMA. 2025 Jan 31. doi: 10.1001/jama.2025.0679. PubMed
December 2024
ANDERER S CDC Calls Attention to Underuse of Antiviral Treatment in Higher-Risk Youth With
Influenza.
JAMA. 2024 Dec 27. doi: 10.1001/jama.2024.25515. PubMed
GENG LN, Erlandson KM, Hornig M, Letts R, et al 2024 Update of the RECOVER-Adult Long COVID Research Index.
JAMA. 2024 Dec 18. doi: 10.1001/jama.2024.24184. PubMedAbstract available
MAIA IS, Kawano-Dourado L, Tramujas L, de Oliveira NE, et al High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute
Respiratory Failure: The RENOVATE Randomized Clinical Trial.
JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.26244. PubMedAbstract available
October 2024
TADROUS M, Callaway Kim K, Hernandez I, Rothenberger SD, et al Differences in Drug Shortages in the US and Canada.
JAMA. 2024 Oct 31. doi: 10.1001/jama.2024.17688. PubMedAbstract available
Audio Highlights: September 14-20, 2024.
JAMA. 2024;332:e2318402. PubMed
HABIB AR, Ijaz N Public Health Crisis in Gaza-Reply.
JAMA. 2024;332:1305-1306. PubMed
JOHANSEN ND, Vaduganathan M, Bhatt AS, Modin D, et al Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic
Diseases: A Randomized Clinical Trial.
JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.21060. PubMedAbstract available
September 2024
AMBA V, Cooper MSL, Sommers BD History Repeats-The Election Battle for Medicaid in 2024.
JAMA. 2024;332:867-868. PubMed
RUBIN R The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long
COVID Benefits.
JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.16432. PubMed
GOODMAN JL, Bright RA, Lurie N H5 Influenza Vaccines-Moving Forward Against Pandemic Threats.
JAMA. 2024 Sep 4. doi: 10.1001/jama.2024.17488. PubMed
SURIE D, Self WH, Zhu Y, Yuengling KA, et al RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and
Older.
JAMA. 2024 Sep 4:e2415775. doi: 10.1001/jama.2024.15775. PubMed
WOOLF SH Increasing Mortality Rates in the US, but Not From COVID-19.
JAMA. 2024 Aug 29. doi: 10.1001/jama.2024.13626. PubMed
AHMAD FB, Cisewski JA, Anderson RN Leading Causes of Death in the US, 2019-2023.
JAMA. 2024 Aug 8. doi: 10.1001/jama.2024.15563. PubMed
HARRIS E Does Infectious Bird Flu Virus Persist After Pasteurization?
JAMA. 2024;332:362. PubMed
HARRIS E NIH Starts Testing Nasal COVID-19 Vaccine in US.
JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13769. PubMed
July 2024
HARRIS E CDC Revises RSV Vaccination Recommendation for Older Adults in US.
JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13385. PubMed
HARRIS E COVID-19 Vaccination in Early Pregnancy Not Linked to Birth Defects.
JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13389. PubMed
YOUMSHAJEKIAN L COVID-19 May Protect Against the Common Cold-Here's Why Knowing That Could Lead
to Better Vaccines.
JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13382. PubMed
ABBASI J As a Third Worker Tests Positive for Bird Flu in US Dairy Cattle Outbreak, Here's
What to Know.
JAMA. 2024;332:267-269. PubMed
AGARWAL SD, Cook BL, Liebman JB Effect of Cash Benefits on Health Care Utilization and Health: A Randomized
Study.
JAMA. 2024 Jul 22:e2413004. doi: 10.1001/jama.2024.13004. PubMedAbstract available
FRIEDL N, Sporreiter M, Winkler C, Heublein A, et al Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19
Infection.
JAMA. 2024 Jul 15:e2411174. doi: 10.1001/jama.2024.11174. PubMed
HARRIS E Symptoms After COVID-19 Vaccination Tied to Higher Antibody Levels.
JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12231. PubMed
RUBIN R Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky.
JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.10992. PubMed
HARRIS E Review Calls for Standardized Long COVID Definition.
JAMA. 2024;332:97. PubMed
FANG Z, Ahrnsbrak R, Rekito A Evidence Mounts That About 7% of US Adults Have Had Long COVID.
JAMA. 2024;332:5-6. PubMed
June 2024
SCRUGGS-WODKOWSKI EA, Malani PN, Linder KA Therapies to Decrease Severe Respiratory Syncytial Virus Illness.
JAMA. 2024;331:2127-2128. PubMed
ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound
Older Adults.
JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673. PubMed
PIRRACCHIO R, Venkatesh B, Legrand M Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary
Infections: A Review.
JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.6096. PubMedAbstract available
VAN DER LINDEN S, Roozenbeek J "Inoculation" to Resist Misinformation.
JAMA. 2024;331:1961-1962. PubMed
ABBASI J Bird Flu Outbreak in Dairy Cows Is Widespread, Raising Public Health Concerns.
JAMA. 2024;331:1789-1791. PubMed
ANGUS DC, Huang AJ, Lewis RJ, Abernethy AP, et al The Integration of Clinical Trials With the Practice of Medicine: Repairing a
House Divided.
JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.4088. PubMedAbstract available
May 2024
HARRIS E Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628. PubMed
HARRIS E Lower Dose of Mpox Vaccine Was Safe, Effective.
JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635. PubMed
KOJIMA N, Blumberg A, Radcliffe R, Flannery B, et al US Public Health Preparedness and Response to Highly Pathogenic Avian Influenza
A(H5N1) Viruses.
JAMA. 2024 May 21:e2410116. doi: 10.1001/jama.2024.10116. PubMed
BOCK A Researchers See Hope in Symptom-Guided Exercise for Long COVID With
Postexertional Malaise.
JAMA. 2024;331:1609-1611. PubMed
HARRIS E CDC: H5N1 Bird Flu Confirmed in Person Exposed to Cattle.
JAMA. 2024;331:1615. PubMed
RUBIN R Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could
Soon Be Available.
JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370. PubMed
XIE Y, Choi T, Al-Aly Z Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter
2023-2024.
JAMA. 2024 May 15:e247395. doi: 10.1001/jama.2024.7395. PubMed
HARRIS E WHO Launches Broad Coronavirus Surveillance Network.
JAMA. 2024 Apr 26. doi: 10.1001/jama.2024.6724. PubMed
ALLEN MR, Desai N, Namazi A, Leas E, et al Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19
Vaccine Misinformation.
JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800. PubMed
HARRIS E Meta-Analysis: "Limited" Benefits to Rapid Viral Tests in EDs.
JAMA. 2024;331:1355. PubMed
HARRIS E Deaths From Excessive Drinking Rose in the US During Pandemic.
JAMA. 2024;331:1355. PubMed
HARRIS E Antidepressant Prescriptions for Female Teens Surged After Pandemic.
JAMA. 2024;331:1266. PubMed
ANDERER S Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493. PubMed
HARRIS E COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152. PubMed
HARRIS E Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155. PubMed
DAWOOD FS, Payne AB, McMorrow ML Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial
Virus.
JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859. PubMed
ANDERER S Study: 1 of Every 9 US Cancer Cases Missed During 2020 Pandemic.
JAMA. 2024;331:1082. PubMed
March 2024
HARRIS E COVID-19 Infection Tied to Slight Cognitive Deficits.
JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087. PubMed
HARRIS E COVID-19 Associated With Higher Risk of Autoimmune Diseases.
JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2092. PubMed
LU Y, Matuska K, Nadimpalli G, Ma Y, et al Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
JAMA. 2024;331:938-950. PubMedAbstract available
HARRIS E CDC Tracking BA.2.87.1, New Omicron Subvariant With Potential to Evade Immunity.
JAMA. 2024;331:907. PubMed
NIELSEN FM, Klitgaard TL, Siegemund M, Laake JH, et al Lower vs Higher Oxygenation Target and Days Alive Without Life Support in
COVID-19: The HOT-COVID Randomized Clinical Trial.
JAMA. 2024 Mar 19:e242934. doi: 10.1001/jama.2024.2934. PubMedAbstract available
SCHWARTZSTEIN RM Oxygen Supplementation in COVID-19-How Much Is Enough?
JAMA. 2024 Mar 19. doi: 10.1001/jama.2024.2935. PubMed
ANDERER S CDC Recommends Additional COVID-19 Booster for Older Adults.
JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071. PubMed
MCKENZIE C, Moore L, Borthwick M Vitamin C for Patients Hospitalized With COVID-19.
JAMA. 2024;331:886. PubMed
ADHIKARI NKJ, Lamontagne F Vitamin C for Patients Hospitalized With COVID-19-Reply.
JAMA. 2024;331:886-887. PubMed
HARRIS E Virtual Group Exercise Program Improved Long COVID Symptoms.
JAMA. 2024;331:822. PubMed
HARRIS E Better Outcomes When Kidney Damage Is From COVID-19.
JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1574. PubMed
HARRIS E HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569. PubMed
HARRIS E Millions of US Children Experience Range of Long COVID Effects.
JAMA. 2024;331:726. PubMed
February 2024
ANDERSSON NW, Thiesson EM, Hviid A Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036. PubMed
HARRIS E New Antiviral on the Horizon for Mild to Moderate COVID-19.
JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0729. PubMed
GRAETZ N, Hepburn P, Gershenson C, Porter SR, et al Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters
Threatened With Eviction.
JAMA. 2024;331:592-600. PubMedAbstract available
RUBIN R When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not
All Alike.
JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014. PubMed
NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
JAMA. 2024;331:396-407. PubMedAbstract available
FELDSTEIN LR, Britton A, Grant L, Wiegand R, et al Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2
Infection in Children and Adolescents Aged 5 to 17 Years.
JAMA. 2024;331:408-416. PubMedAbstract available
January 2024
HARRIS E Missed Vaccine Doses Tied to Worse COVID-19 Outcomes.
JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28340. PubMed
RUBIN R Paxlovid Is Effective but Underused-Here's What the Latest Research Says About
Rebound and More.
JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28254. PubMed
RUBIN R As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2
"Variant of Interest".
JAMA. 2024 Jan 12. doi: 10.1001/jama.2023.27841. PubMed
RUBIN R From "Immunity Debt" to "Immunity Theft"-How COVID-19 Might Be Tied to Recent
Respiratory Disease Surges.
JAMA. 2024 Jan 10. doi: 10.1001/jama.2023.26608. PubMed
HARRIS E High-Dose Flu Vaccine May Be More Effective for Midlife Adults.
JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26114. PubMed
HARRIS E Long COVID in Nursing Home Residents Manifests as Functional Decline.
JAMA. 2024;331:15. PubMed
December 2023
HARRIS E Disproportionate Death Rates Reported in US Prisons Early in the COVID-19
Pandemic.
JAMA. 2023 Dec 27. doi: 10.1001/jama.2023.25770. PubMed
HARRIS E Using Throat Swabs Improved Sensitivity in Detecting SARS-CoV-2.
JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25267. PubMed
HARRIS E Program Offering Free COVID-19 and Flu Services Expands Nationwide.
JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25268. PubMed
HARRIS E Life Expectancy in US Climbed After Declines Related to COVID-19.
JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24683. PubMed
SURAN M Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID.
JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24103. PubMed
RUBIN R Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19
Vaccines.
JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.0644. PubMed
MATHEW P, Feldmann M Treatment of Adults Hospitalized With COVID-19 Pneumonia.
JAMA. 2023;330:2122-2123. PubMed
POWDERLY WG, LaVange L, Bozzette SA Treatment of Adults Hospitalized With COVID-19 Pneumonia-Reply.
JAMA. 2023;330:2123. PubMed
November 2023
EASTMAN Q Study Shows Businesses Selling Unapproved Stem Cell Treatments Have Turned to
Long COVID.
JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23897. PubMed
BERGMAN C Treatment of SARS-CoV-2 Infection in US Nursing Homes.
JAMA. 2023;330:2021-2022. PubMed
MCGARRY BE, Sommers BD, Barnett ML Treatment of SARS-CoV-2 Infection in US Nursing Homes-Reply.
JAMA. 2023;330:2022. PubMed
HARRIS E COVID Moonshot Drove Discovery of Potential COVID-19 Antivirals.
JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22934. PubMed
HARRIS E Smell, Taste Issues After Mild COVID-19 Resolve Over 3 Years.
JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22930. PubMed
HARRIS E Long COVID Linked With Viral Persistence, Serotonin Decline.
JAMA. 2023;330:1827. PubMed
HARRIS E Audit Finds US National Stockpile "Was Not Equipped" for the Pandemic.
JAMA. 2023;330:1828. PubMed
STEWART TG, Rebolledo PA, Mourad A, Lindsell CJ, et al Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With
COVID-19: The ACTIV-6 Randomized Clinical Trial.
JAMA. 2023 Nov 17:e2323363. doi: 10.1001/jama.2023.23363. PubMedAbstract available
HARRIS E Combined COVID-19, Flu Vaccine Candidate Headed to Phase 3 Trials.
JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22353. PubMed
HARRIS E FDA Will Evaluate First Self-Administered FluMist Vaccine.
JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21870. PubMed
HARRIS E Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS.
JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21872. PubMed
HARRIS E HRSA Study: US Abortions Decreased 14% During COVID-19.
JAMA. 2023 Nov 1. doi: 10.1001/jama.2023.21178. PubMed
October 2023
ADHIKARI NKJ, Hashmi M, Tirupakuzhi Vijayaraghavan BK, Haniffa R, et al Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized
Randomized Clinical Trials.
JAMA. 2023 Oct 25:e2321407. doi: 10.1001/jama.2023.21407. PubMedAbstract available
JABALEY CS, Coopersmith CM Vitamin C for Patients With COVID-19: More Evidence of Lack of Efficacy in
Patients With Sepsis.
JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.18592. PubMed
HARRIS E US Survey: About 7% of Adults, 1% of Children Have Had Long COVID.
JAMA. 2023;330:1516. PubMed
KOJIMA N, Peterson L, Hawkins R, Allen M, et al Influenza Antiviral Shortages Reported by State and Territorial Public Health
Officials, 2022-2023.
JAMA. 2023 Oct 20. doi: 10.1001/jama.2023.17244. PubMed
HARRIS E COVID-19 Hospitalizations Up Among Older Adults.
JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19796. PubMed
HARRIS E Previous COVID-19 Linked With Autoimmune Conditions.
JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19798. PubMed
BATRA A, Nath A, Koralnik IJ Postacute Sequelae of SARS-CoV-2 Infection.
JAMA. 2023;330:1491-1492. PubMed
THAWEETHAI T, Foulkes AS Postacute Sequelae of SARS-CoV-2 Infection-Reply.
JAMA. 2023;330:1492. PubMed
HARRIS E Exercise Programs Might Improve Long COVID.
JAMA. 2023;330:1421. PubMed
HARRIS E Changes in SARS-CoV-2 Sequence Linked With Antiviral Use.
JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19202. PubMed
September 2023
HARRIS E NIH Launches Phase 1 Trial of Broader "Universal" Flu Vaccine.
JAMA. 2023 Sep 27. doi: 10.1001/jama.2023.18741. PubMed
HARRIS E Some People Still Have Long COVID Symptoms After 2 Years.
JAMA. 2023;330:1127. PubMed
RUBIN R Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than
6 Months.
JAMA. 2023 Sep 18. doi: 10.1001/jama.2023.19759. PubMed
TARTOF SY, Frankland TB, Slezak JM, Puzniak L, et al Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger
Than 5 Years.
JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17473. PubMed
HARRIS E Two New Analyses Add to Long COVID Understanding.
JAMA. 2023;330:905-906. PubMed
LUGAR M, Eugster A, Achenbach P, von dem Berge T, et al SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood.
JAMA. 2023 Sep 8. doi: 10.1001/jama.2023.16348. PubMedAbstract available
HARRIS E High Blood Pressure More Likely After COVID-19 Than Flu.
JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16676. PubMed
HARRIS E HHS To Invest $1.4 Billion in New COVID-19 Vaccines, Therapies.
JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16678. PubMed
HARRIS E CDC Recommends RSV Immunization for Infants.
JAMA. 2023;330:797. PubMed
HARRIS E Federal Government Announces Long COVID Trials, Research Office.
JAMA. 2023;330:797. PubMed
KENTISH-BARNES N, Resche-Rigon M, Lafarge A, Souppart V, et al PTSD Symptoms Among Family Members of Patients With ARDS Caused by COVID-19 After
12 Months.
JAMA. 2023 Sep 1. doi: 10.1001/jama.2023.15879. PubMed
August 2023
HARRIS E Severe COVID-19 Linked to Enduring Immune System Changes.
JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16109. PubMed
HARRIS E CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant.
JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16105. PubMed
HARRIS E FDA Approves Maternal RSV Vaccine.
JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16106. PubMed
HARRIS E Human Infections With Swine Influenza Viruses Identified in US.
JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15451. PubMed
HARRIS E Lung Transplants for COVID-19 Similarly Successful.
JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15450. PubMed
ABBASI J What to Know About EG.5, the Latest SARS-CoV-2 "Variant of Interest".
JAMA. 2023 Aug 18. doi: 10.1001/jama.2023.16498. PubMed
RUBIN R Why Blood Type Seems to Be Linked With COVID-19 Risk.
JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.15996. PubMed
RAGLOW Z, Malani PN, Petty LA Outpatient Treatment for COVID-19.
JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.16666. PubMed
DOS SANTOS RAS, Taccone FS, Annoni F Renin-Angiotensin System Modulation in Adults With COVID-19.
JAMA. 2023;330:663-664. PubMed
SELF WH, DeClercq J, Orr M Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
JAMA. 2023;330:664-665. PubMed
HARRIS E FDA Approves RSV Monoclonal Antibody for Infants and Young Children.
JAMA. 2023;330:586. PubMed
ABBASI J Vigilance Urged Against Bird Flu Amid Ongoing Outbreaks in Mammals.
JAMA. 2023;330:583-584. PubMed
ABBASI J A Genetic Explanation for Why Some People Had Asymptomatic COVID-19.
JAMA. 2023 Aug 2. doi: 10.1001/jama.2023.14703. PubMed
DAVIDSON BL, Levi MM Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for
COVID-19.
JAMA. 2023;330:471-472. PubMed
GOLIGHER EC, Lawler PR, Zarychanski R Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for
COVID-19-Reply.
JAMA. 2023;330:472-473. PubMed
July 2023
SURAN M HHS Urges Primary Care Clinicians to Help Patients Manage Long COVID's Mental
Health Symptoms.
JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13605. PubMed
HARRIS E Free COVID-19 Vaccinations on the Way for Uninsured Adults.
JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13133. PubMed
GLEASON JL, Tamburro R, Signore C Promoting Data Harmonization of COVID-19 Research in Pregnant and Pediatric
Populations.
JAMA. 2023 Jul 20. doi: 10.1001/jama.2023.10835. PubMed
MCGARRY BE, Sommers BD, Wilcock AD, Grabowski DC, et al Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US
Nursing Homes.
JAMA. 2023 Jul 14:e2312945. doi: 10.1001/jama.2023.12945. PubMed
O'HALLORAN JA, Ko ER, Anstrom KJ, Kedar E, et al Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With
COVID-19 Pneumonia: A Randomized Clinical Trial.
JAMA. 2023 Jul 10:e2311043. doi: 10.1001/jama.2023.11043. PubMedAbstract available
RUBIN R This Fall's COVID-19 Vaccines Will Target Omicron XBB Subvariants, but Who Needs
Them Remains to Be Seen.
JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.10053. PubMed
June 2023
HARRIS E Patients With COVID-19 and Fungal Infections Had High Mortality Rates.
JAMA. 2023 Jun 28. doi: 10.1001/jama.2023.11957. PubMed
MICHAELS D, Wagner GR, Ryan L Lessons From COVID-19 for Protecting Workers in the Next Pandemic.
JAMA. 2023 Jun 16. doi: 10.1001/jama.2023.8229. PubMed
ANDREWS N, Stowe J, Miller E, Ramsay M, et al BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.
JAMA. 2023 Jun 15. doi: 10.1001/jama.2023.10123. PubMed
HARRIS E Hybrid COVID-19 Immunity Common by Fall of 2022.
JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10399. PubMed
HARRIS E Consistent Exercise Tied to Lower Risk of Death From Flu, Pneumonia.
JAMA. 2023;329:1907-1908. PubMed
HARRIS E FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment.
JAMA. 2023 Jun 7. doi: 10.1001/jama.2023.9925. PubMed
May 2023
THAWEETHAI T, Jolley SE, Karlson EW, Levitan EB, et al Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
JAMA. 2023 May 25:e238823. doi: 10.1001/jama.2023.8823. PubMedAbstract available
GROSS R, Lo Re V 3rd Disentangling the Postacute Sequelae of SARS-CoV-2: E Unibus Pluram (From One,
Many).
JAMA. 2023 May 25. doi: 10.1001/jama.2023.8961. PubMed
HARRIS E CDC Updates COVID-19 Data Reporting as US Public Health Emergency Ends.
JAMA. 2023 May 24. doi: 10.1001/jama.2023.9150. PubMed
WEISS A, Donnachie E, Beyerlein A, Ziegler AG, et al Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19.
JAMA. 2023 May 22:e238674. doi: 10.1001/jama.2023.8674. PubMed
HARRIS E WHO Declares End of COVID-19 Global Health Emergency.
JAMA. 2023 May 17. doi: 10.1001/jama.2023.8656. PubMed
HARRIS E COVID-19 Vaccine and Health Care Visits for Menstrual Changes.
JAMA. 2023 May 17. doi: 10.1001/jama.2023.8658. PubMed
HARRIS E FDA Clears RSV Vaccine for Adults Aged 60 Years or Older.
JAMA. 2023 May 17. doi: 10.1001/jama.2023.8657. PubMed
ASHRAF S, Ashraf N Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate
COVID-19.
JAMA. 2023;329:1702. PubMed
MCCARTHY MW, Lindsell CJ, Naggie S Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate
COVID-19-Reply.
JAMA. 2023;329:1702-1703. PubMed
MARCUS R New Alzheimer Disease Drugs, Long COVID and the Central Nervous System, and a
Nasal Spray for Migraines-Highlights From the 2023 American Academy of Neurology
Conference.
JAMA. 2023 May 10. doi: 10.1001/jama.2023.4389. PubMed
HARRIS E RSV Infection Might Be Resuming Prepandemic Patterns.
JAMA. 2023;329:1544. PubMed
HARRIS E BCG Vaccine Not Effective Against COVID-19.
JAMA. 2023 May 3. doi: 10.1001/jama.2023.7763. PubMed
HARRIS E RSV Infection During Infancy Tied to Asthma Later.
JAMA. 2023 May 3. doi: 10.1001/jama.2023.7765. PubMed
HARRIS E XBB.1.16 Deemed COVID-19 "Variant of Interest".
JAMA. 2023 May 3. doi: 10.1001/jama.2023.7768. PubMed
LANDHUIS EW How Primary Care Physicians Can Recognize and Treat Long COVID.
JAMA. 2023 May 3. doi: 10.1001/jama.2023.6604. PubMed
BOMMERSBACH TJ, McKean AJ, Olfson M, Rhee TG, et al National Trends in Mental Health-Related Emergency Department Visits Among Youth,
2011-2020.
JAMA. 2023;329:1469-1477. PubMedAbstract available
April 2023
HARRIS E WHO: Confirmed Avian Influenza Death in China.
JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6622. PubMed
HARRIS E FDA Simplifies COVID-19 Vaccination, Permits Some Additional Doses.
JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6624. PubMed
HARRIS E How Parents' Views Are Tied to Children's COVID-19 Vaccination.
JAMA. 2023 Apr 19. doi: 10.1001/jama.2023.6292. PubMed
HARRIS E RSV Vaccine, Monoclonal Antibody Safe, Effective in Phase 3 Trials.
JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6254. PubMed
HARRIS E Updated WHO Guidance for Prioritizing COVID-19 Vaccines.
JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6256. PubMed
LEE MMY, McMurray JJV Lack of Benefit of Renin-Angiotensin System Inhibitors in COVID-19.
JAMA. 2023;329:1155-1156. PubMed
SELF WH, Shotwell MS, Gibbs KW, de Wit M, et al Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and
Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two
Randomized Clinical Trials.
JAMA. 2023;329:1170-1182. PubMedAbstract available
LAWLER PR, Derde LPG, van de Veerdonk FL, McVerry BJ, et al Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor
Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With
COVID-19: A Randomized Clinical Trial.
JAMA. 2023;329:1183-1196. PubMedAbstract available
XIE Y, Choi T, Al-Aly Z Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in
Fall-Winter 2022-2023.
JAMA. 2023 Apr 6. doi: 10.1001/jama.2023.5348. PubMed
HARRIS E Study: US COVID-19 Outcomes Tied to State Characteristics and Policies.
JAMA. 2023 Apr 5. doi: 10.1001/jama.2023.5622. PubMed
AMMIRATI E, Moslehi JJ Diagnosis and Treatment of Acute Myocarditis: A Review.
JAMA. 2023;329:1098-1113. PubMedAbstract available
HARRIS E Public Had Most Trust in Advice From Physicians, Nurses During Pandemic.
JAMA. 2023;329:1053. PubMed
HARRIS E "Living" Systematic Review of Mental Health During Pandemic.
JAMA. 2023;329:1054. PubMed
HARRIS E Human Flu Cases in Cambodia Not Due to Bird Flu Outbreak Viruses.
JAMA. 2023;329:1053. PubMed
ESMAIL LC, Kapp P, Assi R, Wood J, et al Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical
Trials of Pharmacological Treatments for COVID-19.
JAMA. 2023 Apr 3:e234590. doi: 10.1001/jama.2023.4590. PubMed
March 2023
HARRIS E Cold Virus Provided Cross-reactivity Against SARS-CoV-2 in Children.
JAMA. 2023 Mar 29. doi: 10.1001/jama.2023.5261. PubMed
CAMPO R Illness Metaphors and COVID-19.
JAMA. 2023;329:1035. PubMed
HARRIS E Nasally Administered Monoclonal Antibody for COVID-19.
JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4000. PubMed
LONDON AJ, Seymour CW The Ethics of Clinical Research: Managing Persistent Uncertainty.
JAMA. 2023;329:884-885. PubMed
GOLIGHER EC, Lawler PR, Jensen TP, Talisa V, et al Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients
Hospitalized for COVID-19.
JAMA. 2023 Mar 21. doi: 10.1001/jama.2023.3651. PubMedAbstract available
COKER TR, Cheng TL, Ybarra M Addressing the Long-term Effects of the COVID-19 Pandemic on Children and
Families: A Report From the National Academies of Sciences, Engineering, and
Medicine.
JAMA. 2023 Mar 16. doi: 10.1001/jama.2023.4371. PubMed
HARRIS E FDA Approves First Over-the-counter Combined COVID-19 and Flu Test.
JAMA. 2023 Mar 8. doi: 10.1001/jama.2023.3192. PubMed
SURAN M Long COVID Linked With Unemployment in New Analysis.
JAMA. 2023;329:701-702. PubMed
HARRIS E Meta-analysis: COVID-19 Infection Protects Against Severe Disease.
JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2885. PubMed
HARRIS E Prior COVID-19 Infection Tied to Lasting Lung Abnormalities.
JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2886. PubMed
RUBIN R Highlights From CROI, the Conference on Retroviruses and Opportunistic
Infections-Postexposure Prophylaxis for Sexually Transmitted Infections, a New
Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More.
JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.0158. PubMed
February 2023
NEPRASH HT, Golberstein E, Ganguli I, Chernew ME, et al Association of Evaluation and Management Payment Policy Changes With Medicare
Payment to Physicians by Specialty.
JAMA. 2023;329:662-669. PubMedAbstract available
ABBASI J Bird Flu Has Begun to Spread in Mammals-Here's What's Important to Know.
JAMA. 2023;329:619-621. PubMed
HARRIS E Study: No New SARS-CoV-2 Variants in Recent Outbreak in China.
JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2089. PubMed
HARRIS E COVID-19 Vaccination During Pregnancy Protected Infants.
JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2098. PubMed
LARKIN H National Academies: Expand US Wastewater Disease Surveillance.
JAMA. 2023;329:531. PubMed
NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained
Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
JAMA. 2023 Feb 20:e231650. doi: 10.1001/jama.2023.1650. PubMedAbstract available
BIBBINS-DOMINGO K, Malani PN At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against
COVID-19.
JAMA. 2023 Feb 20. doi: 10.1001/jama.2023.1922. PubMed
HARRIS E NIH Considers Lessons Learned During COVID-19 Pandemic.
JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1553. PubMed
HARRIS E Most COVID-19 Deaths Worldwide Were Among Older People.
JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1554. PubMed
RUBIN R Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual
COVID-19 Vaccines Proposed by the FDA.
JAMA. 2023 Feb 15. doi: 10.1001/jama.2022.22285. PubMed
HARRIS E Updated COVID-19 Guidance for People Who Are Immunocompromised.
JAMA. 2023 Feb 8. doi: 10.1001/jama.2023.1176. PubMed
LARKIN H Newly Discovered Host-Cell Factor Could Be a COVID-19 Treatment Target.
JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0748. PubMed
LARKIN H High COVID-19 Rates Prompt Call for Better Nursing Home Protections.
JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0740. PubMed
LARKIN H Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0743. PubMed
October 2021
RADWANY S Our Best Judgment.
JAMA. 2021;326:1373-1374. PubMed